NeuPath Health Inc.
NPTH.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 53.13M | 51.99M | 51.11M | 50.08M | 48.99M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 53.13M | 51.99M | 51.11M | 50.08M | 48.99M |
| Cost of Revenue | 43.02M | 42.09M | 41.38M | 40.71M | 39.87M |
| Gross Profit | 10.11M | 9.90M | 9.73M | 9.37M | 9.11M |
| SG&A Expenses | 7.41M | 7.26M | 7.15M | 7.00M | 6.86M |
| Depreciation & Amortization | 1.68M | 1.80M | 1.85M | 1.90M | 1.93M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 52.10M | 51.16M | 50.38M | 49.61M | 48.66M |
| Operating Income | 1.03M | 835.30K | 732.80K | 474.10K | 328.70K |
| Income Before Tax | -201.00K | -378.80K | 186.00K | -39.70K | 46.00K |
| Income Tax Expenses | 155.00K | 119.00K | 181.50K | 186.20K | 183.10K |
| Earnings from Continuing Operations | -0.36 | -0.50 | 0.00 | -0.23 | -0.14 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -177.00K | -131.30K | -58.40K | 12.90K | 62.50K |
| Net Income | -533.10K | -629.30K | -54.20K | -213.20K | -74.80K |
| EBIT | 1.03M | 835.30K | 732.80K | 474.10K | 328.70K |
| EBITDA | 2.47M | 2.31M | 2.25M | 2.04M | 1.93M |
| EPS Basic | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.02 | 0.00 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 225.40M | 225.29M | 225.16M | 224.51M | 220.43M |
| Average Diluted Shares Outstanding | 226.20M | 226.09M | 225.98M | 225.26M | 221.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |